Edwin Rock
2023
In 2023, Edwin Rock earned a total compensation of $1.2M as Chief Medical Officer and Senior Vice President at GlycoMimetics.
Compensation breakdown
| Non-Equity Incentive Plan | $198,779 |
|---|---|
| Option Awards | $474,912 |
| Salary | $466,620 |
| Other | $12,000 |
| Total | $1,152,311 |
Rock received $474.9K in option awards, accounting for 41% of the total pay in 2023.
Rock also received $198.8K in non-equity incentive plan, $466.6K in salary and $12K in other compensation.
Rankings
In 2023, Edwin Rock's compensation ranked 969th out of 2,362 executives tracked by ExecPay. In other words, Rock earned more than 59.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 969 out of 2,362 | 59th |
Division Manufacturing | 571 out of 1,281 | 55th |
Major group Chemicals And Allied Products | 391 out of 724 | 46th |
Industry group Drugs | 380 out of 692 | 45th |
Industry Pharmaceutical Preparations | 259 out of 495 | 48th |
Source: SEC filing on April 1, 2024.
Rock's colleagues
We found two more compensation records of executives who worked with Edwin Rock at GlycoMimetics in 2023.